Nuclear medicine : Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. A Radiopharmaceutical is a drug that can be used either for diagnostic or therapeutic purposes.

This report elaborates the market size, market characteristics, and market growth of the Radiopharmaceuticals in Nuclear Medicine industry, and breaks down according to the type, application, and consumption area of Radiopharmaceuticals in Nuclear Medicine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Radiopharmaceuticals in Nuclear Medicine in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Radiopharmaceuticals in Nuclear Medicine market covered in Chapter 13:

Medtronic, Inc.

Bayer AG

Fujifilm Holding Corporation

Jubilant Life science

IBA Group

Cardinal Health

General Electric Co. (healthcare division)

Siemens AG

Curium Pharma

Mallinckrodt plc

Novartis International AG (Advanced accelerator)

Lantheus Medical Imaging, Inc.

Cardinal Health, Inc.

Lantheus Medical Imaging

In Chapter 6, on the basis of types, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 is primarily split into:

Diagnostic

Therapeutic

In Chapter 7, on the basis of applications, the Radiopharmaceuticals in Nuclear Medicine market from 2015 to 2025 covers:

Oncology

Cardiology

Neurology

Thyroid

Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:

United States

Europe

China

Japan

India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)

United States

Canada

Mexico

Europe (Covered in Chapter 9)

Germany

UK

France

Italy

Spain

Others

Asia-Pacific (Covered in Chapter 10)

China

Japan

India

South Korea

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 11)

Saudi Arabia

UAE

South Africa

Others

South America (Covered in Chapter 12)

Brazil

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Radiopharmaceuticals in Nuclear Medicine Market - Research Scope

1.1 Study Goals

1.2 Market Definition and Scope

1.3 Key Market Segments

1.4 Study and Forecasting Years

2 Radiopharmaceuticals in Nuclear Medicine Market - Research Methodology

2.1 Methodology

2.2 Research Data Source

2.2.1 Secondary Data

2.2.2 Primary Data

2.2.3 Market Size Estimation

2.2.4 Legal Disclaimer

3 Radiopharmaceuticals in Nuclear Medicine Market Forces

3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size

3.2 Top Impacting Factors (PESTEL Analysis)

3.2.1 Political Factors

3.2.2 Economic Factors

3.2.3 Social Factors

3.2.4 Technological Factors

3.2.5 Environmental Factors

3.2.6 Legal Factors

3.3 Industry Trend Analysis

3.4 Industry Trends Under COVID-19

3.4.1 Risk Assessment on COVID-19

3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry

3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario

3.5 Industry Risk Assessment

4 Radiopharmaceuticals in Nuclear Medicine Market - By Geography

4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Value and Market Share by Regions

4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Value ($) by Region (2015-2020)

4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Value Market Share by Regions (2015-2020)

4.2 Global Radiopharmaceuticals in Nuclear Medicine Market Production and Market Share by Major Countries

4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Production by Major Countries (2015-2020)

4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Major Countries (2015-2020)

4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Consumption and Market Share by Regions

4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2015-2020)

4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions (2015-2020)

5 Radiopharmaceuticals in Nuclear Medicine Market - By Trade Statistics

5.1 Global Radiopharmaceuticals in Nuclear Medicine Export and Import

5.2 United States Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

5.3 Europe Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

5.4 China Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

5.5 Japan Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

5.6 India Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

5.7

6 Radiopharmaceuticals in Nuclear Medicine Market - By Type

6.1 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Types (2015-2020)

6.1.1 Global Radiopharmaceuticals in Nuclear Medicine Production by Types (2015-2020)

6.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Types (2015-2020)

6.2 Global Radiopharmaceuticals in Nuclear Medicine Value and Market Share by Types (2015-2020)

6.2.1 Global Radiopharmaceuticals in Nuclear Medicine Value by Types (2015-2020)

6.2.2 Global Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types (2015-2020)

6.3 Global Radiopharmaceuticals in Nuclear Medicine Production, Price and Growth Rate of Diagnostic (2015-2020)

6.4 Global Radiopharmaceuticals in Nuclear Medicine Production, Price and Growth Rate of Therapeutic (2015-2020)

7 Radiopharmaceuticals in Nuclear Medicine Market - By Application

7.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Market Share by Applications (2015-2020)

7.1.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption by Applications (2015-2020)

7.1.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Applications (2015-2020)

7.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Oncology (2015-2020)

7.3 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Cardiology (2015-2020)

7.4 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Neurology (2015-2020)

7.5 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Thyroid (2015-2020)

7.6 Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate of Others (2015-2020)

8 North America Radiopharmaceuticals in Nuclear Medicine Market

8.1 North America Radiopharmaceuticals in Nuclear Medicine Market Size

8.2 United States Radiopharmaceuticals in Nuclear Medicine Market Size

8.3 Canada Radiopharmaceuticals in Nuclear Medicine Market Size

8.4 Mexico Radiopharmaceuticals in Nuclear Medicine Market Size

8.5 The Influence of COVID-19 on North America Market

9 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis

9.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size

9.2 Germany Radiopharmaceuticals in Nuclear Medicine Market Size

9.3 United Kingdom Radiopharmaceuticals in Nuclear Medicine Market Size

9.4 France Radiopharmaceuticals in Nuclear Medicine Market Size

9.5 Italy Radiopharmaceuticals in Nuclear Medicine Market Size

9.6 Spain Radiopharmaceuticals in Nuclear Medicine Market Size

9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Analysis

10.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size

10.2 China Radiopharmaceuticals in Nuclear Medicine Market Size

10.3 Japan Radiopharmaceuticals in Nuclear Medicine Market Size

10.4 South Korea Radiopharmaceuticals in Nuclear Medicine Market Size

10.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size

10.6 India Radiopharmaceuticals in Nuclear Medicine Market Size

10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Analysis

11.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size

11.2 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size

11.3 UAE Radiopharmaceuticals in Nuclear Medicine Market Size

11.4 South Africa Radiopharmaceuticals in Nuclear Medicine Market Size

11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Radiopharmaceuticals in Nuclear Medicine Market Analysis

12.1 South America Radiopharmaceuticals in Nuclear Medicine Market Size

12.2 Brazil Radiopharmaceuticals in Nuclear Medicine Market Size

12.3 The Influence of COVID-19 on South America Market

13 Company Profiles

13.1 Medtronic, Inc.

13.1.1 Medtronic, Inc. Basic Information

13.1.2 Medtronic, Inc. Product Profiles, Application and Specification

13.1.3 Medtronic, Inc. Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.2 Bayer AG

13.2.1 Bayer AG Basic Information

13.2.2 Bayer AG Product Profiles, Application and Specification

13.2.3 Bayer AG Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.3 Fujifilm Holding Corporation

13.3.1 Fujifilm Holding Corporation Basic Information

13.3.2 Fujifilm Holding Corporation Product Profiles, Application and Specification

13.3.3 Fujifilm Holding Corporation Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.4 Jubilant Life science

13.4.1 Jubilant Life science Basic Information

13.4.2 Jubilant Life science Product Profiles, Application and Specification

13.4.3 Jubilant Life science Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.5 IBA Group

13.5.1 IBA Group Basic Information

13.5.2 IBA Group Product Profiles, Application and Specification

13.5.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.6 Cardinal Health

13.6.1 Cardinal Health Basic Information

13.6.2 Cardinal Health Product Profiles, Application and Specification

13.6.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.7 General Electric Co. (healthcare division)

13.7.1 General Electric Co. (healthcare division) Basic Information

13.7.2 General Electric Co. (healthcare division) Product Profiles, Application and Specification

13.7.3 General Electric Co. (healthcare division) Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.8 Siemens AG

13.8.1 Siemens AG Basic Information

13.8.2 Siemens AG Product Profiles, Application and Specification

13.8.3 Siemens AG Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.9 Curium Pharma

13.9.1 Curium Pharma Basic Information

13.9.2 Curium Pharma Product Profiles, Application and Specification

13.9.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.10 Mallinckrodt plc

13.10.1 Mallinckrodt plc Basic Information

13.10.2 Mallinckrodt plc Product Profiles, Application and Specification

13.10.3 Mallinckrodt plc Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.11 Novartis International AG (Advanced accelerator)

13.11.1 Novartis International AG (Advanced accelerator) Basic Information

13.11.2 Novartis International AG (Advanced accelerator) Product Profiles, Application and Specification

13.11.3 Novartis International AG (Advanced accelerator) Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.12 Lantheus Medical Imaging, Inc.

13.12.1 Lantheus Medical Imaging, Inc. Basic Information

13.12.2 Lantheus Medical Imaging, Inc. Product Profiles, Application and Specification

13.12.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.13 Cardinal Health, Inc.

13.13.1 Cardinal Health, Inc. Basic Information

13.13.2 Cardinal Health, Inc. Product Profiles, Application and Specification

13.13.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

13.14 Lantheus Medical Imaging

13.14.1 Lantheus Medical Imaging Basic Information

13.14.2 Lantheus Medical Imaging Product Profiles, Application and Specification

13.14.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medicine Market Performance (2015-2020)

14 Market Forecast - By Regions

14.1 North America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2020-2025)

14.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast (2020-2025)

14.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast (2020-2025)

14.4 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast (2020-2025)

14.5 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications

15.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Types (2020-2025)

15.1.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Production and Market Share by Types (2020-2025)

15.1.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Value and Market Share by Types (2020-2025)

15.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Applications (2020-2025)

List of Tables and Figures

Figure Radiopharmaceuticals in Nuclear Medicine Picture

Table Radiopharmaceuticals in Nuclear Medicine Key Market Segments

Figure Study and Forecasting Years

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate 2015-2025

Figure Industry PESTEL Analysis

Figure Global COVID-19 Status

Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19

Figure Global Radiopharmaceuticals in Nuclear Medicine Value ($) and Growth Rate (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Value ($) by Countries (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Value Market Share by Regions (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Value Market Share by Regions in 2019

Figure Global Radiopharmaceuticals in Nuclear Medicine Production and Growth Rate (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Production by Major Countries (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Major Countries (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Regions in 2019

Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Regions in 2019

Table Global Radiopharmaceuticals in Nuclear Medicine Export Top 3 Country 2019

Table Global Radiopharmaceuticals in Nuclear Medicine Import Top 3 Country 2019

Table United States Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

Table Europe Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

Table China Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

Table Japan Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

Table India Radiopharmaceuticals in Nuclear Medicine Export and Import (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Production by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Types (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Share by Type (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Value by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Value Market Share by Types (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Value Share by Type (2015-2020)

Figure Global Diagnostic Production and Growth Rate (2015-2020)

Figure Global Diagnostic Price (2015-2020)

Figure Global Therapeutic Production and Growth Rate (2015-2020)

Figure Global Therapeutic Price (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Consumption by Applications (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Applications (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Consumption Share by Application (2015-2020)

Figure Global Oncology Consumption and Growth Rate (2015-2020)

Figure Global Cardiology Consumption and Growth Rate (2015-2020)

Figure Global Neurology Consumption and Growth Rate (2015-2020)

Figure Global Thyroid Consumption and Growth Rate (2015-2020)

Figure Global Others Consumption and Growth Rate (2015-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table North America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2015-2020)

Table North America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure United States Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2015-2020)

Table Europe Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure United Kingdom Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure France Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Europe COVID-19 Status

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2015-2020)

Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure China Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure South Korea Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure India Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2015-2020)

Table Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure UAE Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table South America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2015-2020)

Table South America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries (2015-2020)

Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Consumption and Growth Rate (2015-2020)

Table Medtronic, Inc. Company Profile

Table Medtronic, Inc. Production, Value, Price, Gross Margin 2015-2020

Figure Medtronic, Inc. Production and Growth Rate

Figure Medtronic, Inc. Value ($) Market Share 2015-2020

Table Bayer AG Company Profile

Table Bayer AG Production, Value, Price, Gross Margin 2015-2020

Figure Bayer AG Production and Growth Rate

Figure Bayer AG Value ($) Market Share 2015-2020

Table Fujifilm Holding Corporation Company Profile

Table Fujifilm Holding Corporation Production, Value, Price, Gross Margin 2015-2020

Figure Fujifilm Holding Corporation Production and Growth Rate

Figure Fujifilm Holding Corporation Value ($) Market Share 2015-2020

Table Jubilant Life science Company Profile

Table Jubilant Life science Production, Value, Price, Gross Margin 2015-2020

Figure Jubilant Life science Production and Growth Rate

Figure Jubilant Life science Value ($) Market Share 2015-2020

Table IBA Group Company Profile

Table IBA Group Production, Value, Price, Gross Margin 2015-2020

Figure IBA Group Production and Growth Rate

Figure IBA Group Value ($) Market Share 2015-2020

Table Cardinal Health Company Profile

Table Cardinal Health Production, Value, Price, Gross Margin 2015-2020

Figure Cardinal Health Production and Growth Rate

Figure Cardinal Health Value ($) Market Share 2015-2020

Table General Electric Co. (healthcare division) Company Profile

Table General Electric Co. (healthcare division) Production, Value, Price, Gross Margin 2015-2020

Figure General Electric Co. (healthcare division) Production and Growth Rate

Figure General Electric Co. (healthcare division) Value ($) Market Share 2015-2020

Table Siemens AG Company Profile

Table Siemens AG Production, Value, Price, Gross Margin 2015-2020

Figure Siemens AG Production and Growth Rate

Figure Siemens AG Value ($) Market Share 2015-2020

Table Curium Pharma Company Profile

Table Curium Pharma Production, Value, Price, Gross Margin 2015-2020

Figure Curium Pharma Production and Growth Rate

Figure Curium Pharma Value ($) Market Share 2015-2020

Table Mallinckrodt plc Company Profile

Table Mallinckrodt plc Production, Value, Price, Gross Margin 2015-2020

Figure Mallinckrodt plc Production and Growth Rate

Figure Mallinckrodt plc Value ($) Market Share 2015-2020

Table Novartis International AG (Advanced accelerator) Company Profile

Table Novartis International AG (Advanced accelerator) Production, Value, Price, Gross Margin 2015-2020

Figure Novartis International AG (Advanced accelerator) Production and Growth Rate

Figure Novartis International AG (Advanced accelerator) Value ($) Market Share 2015-2020

Table Lantheus Medical Imaging, Inc. Company Profile

Table Lantheus Medical Imaging, Inc. Production, Value, Price, Gross Margin 2015-2020

Figure Lantheus Medical Imaging, Inc. Production and Growth Rate

Figure Lantheus Medical Imaging, Inc. Value ($) Market Share 2015-2020

Table Cardinal Health, Inc. Company Profile

Table Cardinal Health, Inc. Production, Value, Price, Gross Margin 2015-2020

Figure Cardinal Health, Inc. Production and Growth Rate

Figure Cardinal Health, Inc. Value ($) Market Share 2015-2020

Table Lantheus Medical Imaging Company Profile

Table Lantheus Medical Imaging Production, Value, Price, Gross Margin 2015-2020

Figure Lantheus Medical Imaging Production and Growth Rate

Figure Lantheus Medical Imaging Value ($) Market Share 2015-2020

Figure North America Market Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)

Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Consumption and Growth Rate Forecast (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Production by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Production Share by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Value ($) by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Value Share by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Consumption by Applications (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Consumption Share by Applications (2020-2025)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)